PHARMASSET INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 47 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-11-01: Reporting owner Rogers Michael D.; Form 4; Security Stock Option (Right to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-10-10: Reporting owner OTTO MICHAEL; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-10-10: Reporting owner Carney William J; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-10-10: Reporting owner Williamson Robert F III; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-11-01 | Rogers Michael D. Officer (Chief Development Officer) | 4 | Stock Option (Right to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $13.88 exercise price | 2007-11-08 | |
| 2007-10-10 | OTTO MICHAEL Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $18.60 exercise price | 2008-11-19 | |
| 2007-10-10 | Carney William J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $13.67 exercise price | 2008-01-18 | |
| 2007-10-10 | Williamson Robert F III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $13.67 exercise price | 2008-01-18 | |
| 2007-10-10 | Price P Schaefer Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +93,000 93,000 owned after | $13.67 exercise price | 2008-01-18 | |
| 2007-10-10 | OTTO MICHAEL Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $13.67 exercise price | 2008-01-18 | |
| 2007-10-10 | INOUYE MICHAEL K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $13.67 exercise price | 2008-01-18 | |
| 2007-10-10 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Richt to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $13.67 exercise price | 2008-01-18 | |
| 2007-10-10 | LEUTZINGER KURT Officer (Chief Financial Officer) | 4 | Stock Option (Richt to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +31,000 31,000 owned after | $13.67 exercise price | 2008-01-18 | |
| 2007-10-10 | BURRILL STEVEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $13.67 exercise price | 2008-01-18 | |
| 2007-10-10 | PRICE FREDRIC D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $13.67 exercise price | 2008-01-18 | |
| 2007-10-10 | HAHN ELLIOT F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $13.67 exercise price | 2008-01-18 | |
| 2007-09-05 | OTTO MICHAEL Officer (Exec.VP,Pharm.Research) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 83,333 owned after | $3.00 exercise price | 2007-09-17 | |
| 2007-08-09 | LEUTZINGER KURT Officer (Executive VP & CFO) | 4 | Stock Option (Richt to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,833 63,000 owned after | $3.00 exercise price | 2007-08-13 | |
| 2007-05-02 | Price P Schaefer Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,667 66,667 owned after | $9.00 exercise price | 2007-05-04 | |
| 2007-04-26 holding as of filing | Berrey M Michelle Officer (VP, Clinical Development & CMO) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.20 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | LEUTZINGER KURT Officer (Executive VP & CFO) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.00 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | LEUTZINGER KURT Officer (Executive VP & CFO) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.87 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | LEUTZINGER KURT Officer (Executive VP & CFO) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.02 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | OTTO MICHAEL Officer (Exec.VP, Pharm. Research) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.55 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | OTTO MICHAEL Officer (Exec.VP, Pharm. Research) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | OTTO MICHAEL Officer (Exec.VP, Pharm. Research) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.00 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | OTTO MICHAEL Officer (Exec.VP, Pharm. Research) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.87 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | OTTO MICHAEL Officer (Exec.VP, Pharm. Research) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.02 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Price P Schaefer Director, Officer (President and CEO) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.00 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Price P Schaefer Director, Officer (President and CEO) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.87 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Price P Schaefer Director, Officer (President and CEO) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.02 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Williamson Robert F III Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.00 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Williamson Robert F III Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.87 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Williamson Robert F III Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.87 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Williamson Robert F III Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.02 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | PRICE FREDRIC D Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.45 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Carney William J Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.75 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Carney William J Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.00 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Carney William J Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.87 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Carney William J Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.02 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | INOUYE MICHAEL K Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.00 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | INOUYE MICHAEL K Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.02 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HAHN ELLIOT F Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HAHN ELLIOT F Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.75 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HAHN ELLIOT F Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.75 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HAHN ELLIOT F Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.75 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HAHN ELLIOT F Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.75 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HAHN ELLIOT F Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.00 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HAHN ELLIOT F Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.87 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HAHN ELLIOT F Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.87 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HAHN ELLIOT F Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.02 exercise price | 2007-04-26 |